BSEInsider Trading / SAST6d ago · 14 Aug 2026, 02:42 pm
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Claymore Investments (Mauritius) Pte Ltd
Dr. Agarwals Health Care Ltd · 544350
✦ AI SummaryPledge
Claymore Investments (Mauritius) Pte. Ltd. has disclosed a sale of 1,59,00,000 shares of Dr. Agarwals Health Care Ltd, reducing their stake from 20.06% to 15.04%.
Analysis Scores
Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Dr. Agarwals Health Care Ltd - 544350 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Attachments (1)
📄pdf
Download →
1B52728B_2C36_45CC_9D5B_332178D5CF42_144245.pdf
View document text
Claymore Investments (Mauritius) Pte. Ltd.
Registration No. 076038 (C1/GBL)
August 13, 2026
Dr.Agarwals Health Care Limited
6th Floor, Menon Eternity,
1st Main Road,
Austin Nagar, Alwarpet,
Chennai, Tamil Nadu, 600018
BSE Limited
Listing Department
1stFloor, New Trading Ring
Rotunda Building
P.J. Tower
Dalal Street, Fort
Mumbai 400 001
National Stock Exchange of IndiaLimited
Listing Department
Exchange Plaza, 5thFloor
Plot No. C/1, G-Block
Bandra Kurla Complex
Bandra(East)
Mumbai 400 051
Dear Sir,
Sub: Disclosure under Regulation 29(2)of the Securities and Exchange Board of India (Substantial
Acquisition of Shares and Takeovers) Regulations, 2011.
Please find attached the disclosure under Regulation 29 (2) of the Securities and Exchange Board of India
(Substantial Acquisition of Shares and Takeovers) Regulations, 2011 with respect to the sale of shares of
Dr.Agarwals Health Care Limitedby Claymore Investments (Mauritius) Pte. Ltd.
Yours faithfully,
For and on behalf of Claymore Investments (Mauritius) Pte. Ltd.
Authorised signatory
Name:
Designation:
Disclosures under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers)
Regulations, 2011
Part A - Details of the Sale
Name of the Target Company Dr. Agarwal’s Health Care Limited
(TC)
Name(s) of the seller and Persons Seller - Claymore Investments (Mauritius) Pte. Ltd.
Acting in Concert (PAC) with the
seller PAC– Arvon Investments Pte. Ltd.
Whether the seller belongs to No
Promoter/Promoter group
Name(s) of the Stock Exchange(s) BSE Limited and National Stock Exchange of India Limited
where the shares of TC are Listed
Details of the sale are as follows Number % w.r.t. total % w.r.t. total
share/voting diluted
capital wherever share/voting
applicable (*) capital of the
TC (**)
Before the sale under
consideration, holding of:
a) Shares carrying voting Seller - 3,22,96,300 Seller – 10.19% Seller- 10.12%
rights PAC - 3,12,75,470 PAC – 9.87% PAC– 9.80%
b) Shares in the nature of
encumbrance (pledge/ lien/ Nil Nil Nil
non-disposal undertaking/
others)
c) Voting rights (VR)
Nil Nil Nil
otherwise than by shares
d) Warrants/convertible
Nil Nil Nil
securities/any other
instrument that entitles the
acquirer to receive shares
carrying voting rights in the
TC (specify holding in each
category)
e) Total (a+b+c+d)
6,35,71,770 20.06% 19.91%
Details of acquisition / sale
a) Shares carrying voting rights Seller – 1,59,00,000 Seller – 5.02% Seller-4.98%
acquired/sold PAC - NIL PAC - NIL PAC - NIL
b) VRs acquired/sold otherwise Nil Nil Nil
than by shares
c) Warrants/convertible Nil Nil Nil
securities/any other
instrument that entitles the
acquirer to receive shares
carrying voting rights in the
TC (specify holding in each
category) acquired/sold
Nil Nil Nil
d) Shares
encumbered/invoked/releas
ed by the acquirer
1,59,00,000 5.02% 4.98%
e) Total (a+b+c+/-d)
After the acquisition/sale
holding of:
a) Shares carrying voting rights Seller – 1,63,96,300 Seller – 5.17% Seller-5.14%
PAC - 3,12,75,470 PAC – 9.87% PAC – 9.80%
b) Shares encumbered with the Nil Nil Nil
acquirer
c) VRs otherwise than by
shares Nil Nil Nil
d) Warrants/convertible Nil Nil Nil
securities/any other
instrument that entitles the
acquirer to receive shares
carrying voting rights in the
TC (specify holding in each
category) after acquisition
e) Total (a+b+c+d) 4,76,71,770 15.04% 14.93%
Mode of acquisition / sale (e.g. Sale on the open market
open market / off-market/ public
issue / rights issue / preferential
allotment / inter-se transfer etc.)
Date of acquisition/sale of The 2% limit was crossed on August 12, 2026.
shares/VR or date of receipt of
intimation of allotment of shares
whichever is applicable.
Equity share capital / total voting INR 31,69,83,028 comprising 31,69,83,028 equity shares of face
capital of the TC before the said value of INR 1/- each.
acquisition/sale(*)
Equity share capital/ total voting INR 31,69,83,028 comprising 31,69,83,028 equity shares of face
capital of the TC after the said value of INR 1/- each.
acquisition/sale(*)
Total diluted share/voting capital INR 31,92,62,876 comprising 31,92,62,876 equity shares of face
of the TC after the said sale (**) value of INR 1/- each.
Note:
(*) Total share capital/ voting capital to be taken as per the latest filing done by the company to the Stock
Exchange under Clause 35 of the listing Agreement i.e. as on June 30, 2026.
(**) Diluted share/voting capital means the total number of shares in the TC assuming full conversion of
the outstanding convertible securities/warrants into equity shares of the TC as on June 30, 2026.
(#) All percentage shareholding in this disclosure has been rounded-up to two decimal places for the ease
of reference.
Signatureoftheacquirer/seller / Authorised Signatory
For Claymore Investments (Mauritius) Pte. Ltd.
Name:
Designation: AuthorisedSignatory
Place:
Date: